1. Introduction {#sec1-biology-09-00220}
===============

A new human coronavirus started spreading in Wuhan, China, by the end of 2019, and turned into a pandemic disease called COVID-19 as declared by the World Health Organization on 11 March 2020. Since then, the affected countries and cities around the world have been reacting in different ways, towards locally controlling the disease evolution. These measures include general isolation through quarantine and massive testing for focused isolation, with varying degrees of success so far, as can be analyzed from the limited data available. Naturally, China offers the earliest and longest time series on reported infectious cases and the resulting effects of combining different public health interventions. As of 26 March 2020, there were no reports in China of further internal contaminations, and all the new cases were associated with infected individuals that (re)entered in the country. Despite the apparent success of the interventions in China, each region or country might require a specific combination of measures, due to demographic spatial distribution and age structure, health system capabilities, and social-economical characteristics. In this sense, it urges to have a mathematical model that would allow for the simulation of such possible interventions on the epidemy evolution within the short and long terms. This article presents a collaborative research effort towards the construction of an epidemy evolution prediction tool, which combines direct and inverse problem analysis and is both reliable and easy to implement and execute. This work was initially motivated towards offering some insight into the control of COVID-19 within Brazil since its early stage of evolution.

The classical susceptible-infectious-recovered (SIR) model describes the transmission of diseases between susceptible and infectious individuals and provides the basic framework for almost all phenomenological epidemic models. At the onset of the coronavirus epidemy in China, there were some initial studies for the prediction of its evolution and the analysis of the impact of public health measures \[[@B1-biology-09-00220]\], which however did not consider in the modeling the presence of unreported infectious individuals cases, which are in practice inherent to this process. The present work is thus based on the SIRU-type model proposed in Reference \[[@B2-biology-09-00220]\], which deals with the epidemic outbreak in Wuhan by introducing the unreported cases in the modeling, and evaluating the consequences of public health interventions. This was a direct application of previous developments \[[@B3-biology-09-00220],[@B4-biology-09-00220]\] on the fundamental problem of parameter estimation in mathematical epidemic models, accounting for unreported symptomatic infectious individuals. This same modeling approach was later on employed in the analysis of the epidemic outbreak in different countries, including China, South Korea, Germany, Italy, United Kingdom, Spain, and France \[[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220],[@B8-biology-09-00220]\]. Besides identifying unreported cases, this simple and robust model also introduces a latency period and a time variable transmission rate, which can simulate a public health orientation change, such as in a general isolation measure. In addition, an exponential analytical behavior is assumed for the accumulated reported cases evolution along with an initial phase just following the onset of the epidemy, which, upon fitting of the available data, allows for the explicit analytical estimation of the transmission rate and the associated initial conditions required by the model.

Here, the SIRU-type model in References \[[@B2-biology-09-00220],[@B3-biology-09-00220],[@B4-biology-09-00220],[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220],[@B8-biology-09-00220],[@B9-biology-09-00220],[@B10-biology-09-00220],[@B11-biology-09-00220]\] is implemented for the direct problem formulation of the COVID-19 epidemy evolution, adding a time variable parametrization for the fraction of asymptomatic infectious that become reported symptomatic individuals, a very important parameter in the public health measure associated with massive testing and consequent focused isolation. The same analytical identification procedure is maintained for the required initial conditions, as obtained from the early stage exponential behavior assumption \[[@B2-biology-09-00220],[@B3-biology-09-00220],[@B4-biology-09-00220],[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220],[@B8-biology-09-00220]\]. However, a Bayesian inference approach is here adopted for parametric estimations, complementing these analytical estimates obtained through the hypothesis of exponential growth in the early stage of the epidemy, before any public health intervention. Other recent contributions have successfully combined phenomenological deterministic compartmental models with Bayesian inference approaches for state estimation and parameter estimation \[[@B12-biology-09-00220],[@B13-biology-09-00220],[@B14-biology-09-00220],[@B15-biology-09-00220],[@B16-biology-09-00220]\]. For the present purposes, the Markov Chain Monte Carlo method with the Metropolis-Hastings sampling algorithm has been employed \[[@B17-biology-09-00220],[@B18-biology-09-00220],[@B19-biology-09-00220],[@B20-biology-09-00220],[@B21-biology-09-00220]\]. At first, the goal of the inverse problem analysis was estimating the parameters associated with the transmission rate and the fraction of asymptomatic infectious that become reported symptomatic individuals, which can be quite different in the various regions and countries and may also vary according to the public health measures. Then, in light of the success in this parametrization and on the estimation of the required coefficients, an extended estimation was also implemented which incorporates the average time the asymptomatic infectious are asymptomatic and the average time the infectious stay in the symptomatic condition, due to the noticeable uncertainty on these parameters in the medical literature. The proposed approach was then applied to the data from China, initially by taking just the first portion of these data points in the estimation, while using the second portion to validate the model using the estimated parameters with just the first phase of the epidemy evolution, and later on by employing the whole time series in the MCMC estimation procedure, thus identifying parameters for the whole evolution period. This second estimation was particularly aimed at refining the data for the average times that asymptomatic infectious individuals and symptomatic individuals remain infectious. Upon validation of the approach through the data for China, we have proceeded to the analysis of the epidemy dynamics in Brazil, employing 35 days (15 February until 29 March) of collected information on reported symptomatic infectious individuals. First, this initial phase data was employed in the estimation of parameters, followed by the prediction of the epidemy evolution in Brazil. For this purpose, the following days (up to day 60) were reserved to be used in the validation of the proposed model for the COVID-19 evolution in Brazil during this initial phase. Then, we have explored the time variation of both the transmission rate and the fraction of asymptomatic infections that become reported symptomatic individuals, to reflect public health interventions, in simulating possible government measures, as described in different scenarios. Finally, the full dataset of reported cases available by completion of this work, was employed in the redefinition of the model to provide predictions of the epidemy evolution based on more recent observations at that particular moment.

2. The Forward SIRU-Type Model {#sec2-biology-09-00220}
==============================

The implemented SIRU-type model \[[@B2-biology-09-00220],[@B3-biology-09-00220],[@B4-biology-09-00220],[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220],[@B8-biology-09-00220]\] is given by the following initial value problem:$$\frac{dS\left( t \right)}{dt} = - \tau\left( t \right)S\left( t \right)\left\lbrack {I\left( t \right) + U\left( t \right)} \right\rbrack$$ $$\frac{dI\left( t \right)}{dt} = \tau\left( t \right)S\left( t \right)\left\lbrack {I\left( t \right) + U\left( t \right)} \right\rbrack - \nu I\left( t \right)$$ $$\frac{dR\left( t \right)}{dt} = \nu_{1}\left( t \right)I\left( t \right) - \eta R\left( t \right)$$ $$\frac{dU\left( t \right)}{dt} = \nu_{2}\left( t \right)I\left( t \right) - \eta U\left( t \right)$$ where, $$\nu_{1}\left( t \right) = \nu f\left( t \right)$$ $$\nu_{2}\left( t \right) = \nu\left( {1 - f\left( t \right)} \right)$$ with initial conditions $${S\left( t_{0} \right) = S_{0}}{}$$ $${I\left( t_{0} \right) = I_{0}}{}$$ $${R\left( t_{0} \right) = 0}{}$$ $${U\left( t_{0} \right) = U_{0}}{}$$

Here, *t~0~* is the beginning date of the epidemy in days, *S*(*t*) is the number of individuals susceptible to infection at time t, *I*(*t*) is the number of asymptomatic infectious individuals at time t, *R*(*t*) is the number of reported symptomatic infectious individuals (i.e., symptomatic infections with mild to severe symptoms) at time t, and *U*(*t*) is the number of unreported symptomatic infectious individuals (i.e., symptomatic infections with light to mild symptoms) at time t. Asymptomatic infectious individuals *I*(*t*) are infectious for an average period of 1/*ν* days. Reported symptomatic individuals *R*(*t*) are infectious for an average period of 1/*η* days, as are unreported symptomatic individuals *U*(*t*). We assume that reported symptomatic infectious individuals *R*(*t*) are reported and isolated immediately and cause no further infections. The asymptomatic individuals *I*(*t*) can also be viewed as having a low-level symptomatic state. All infections are acquired from either *I*(*t*) or *U*(*t*) individuals. The fraction *f*(*t*) of asymptomatic infections become reported symptomatic infections, and the fraction 1 − *f*(*t*) becomes unreported symptomatic infections. The rate that asymptomatic infectious become reported symptomatic is ν~1~(*t*) = *f*(*t*)ν, while the rate that asymptomatic infections become unreported symptomatic is *ν*~2~(*t*) = (1 − *f*(*t*)) *ν*, where *ν*~1~(*t*) + *ν*~2~(*t*) = *ν*. The transmission rate, *τ*(*t*), is also allowed to be a time variable function along the evolution process. [Figure 1](#biology-09-00220-f001){ref-type="fig"} below illustrates the infection process as a flow chart.

The time variable coefficients, *τ*(*t*) and *f*(*t*), are chosen to be expressed as:$$\tau\left( t \right) = \tau_{0}\ ,\ 0 \leq t \leq N$$ $$\tau\left( t \right) = \tau_{0}\exp\left( {- \mu\left( {t - N} \right)} \right),\ t > N$$ $$f\left( t \right) = f_{0}\ ,\ 0 \leq t \leq N_{f}$$ $$f\left( t \right) = \left( {f_{max -}f_{0}} \right)\left\lbrack {1 - \exp\left( {- \mu_{f}\left( {t - N_{f}} \right)} \right)} \right\rbrack + f_{0},\ t > N_{f}$$

These parametrized functions are particularly useful in interpreting the effects of public health interventions. For instance, the transmission rate, $\tau\left( t \right)$, is particularly affected by a reduced circulation achieved through a general isolation or quarantine measure or by the relaxation of this social distancing, while the fraction $f\left( t \right)$ of asymptomatic infections that become reported, thus isolated, cases can be drastically increased by a massive testing measure with focused isolation. In the above relations, $\mu$ is the attenuation factor for the transmission rate, N is the starting time in days for application of the public health intervention to change transmission rate, while $\mu_{f}$ is the argument of the *f*(*t*) variation between the limits ($f_{0},\ f_{max}$). The first time variable function has been previously considered in References \[[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220],[@B8-biology-09-00220]\], while the second one has been introduced in the present work, to allow for the examination of combined measures. Existence and uniqueness of positive solutions for nonlinear SIRU-type models, which include system (1) as a special case, have been more closely discussed in References \[[@B22-biology-09-00220],[@B23-biology-09-00220]\]. Moreover, it should be recalled that the present class of ordinary differential deterministic model is more appropriate to regions with fairly homogeneous spatial behavior and characteristics, since the spatial spread of epidemic disease in a geographical setting \[[@B23-biology-09-00220]\] is not explicitly accounted for in the present work.

The cumulative number of reported cases at time *t*, $CR\left( t \right)$, which is the quantity offered by the actual available data, and the a priori unknown cumulative number of unreported cases, $CU\left( t \right)$, are given by:$$CR\left( t \right) = \int_{t_{0}}^{t}\nu_{1}\left( s \right)I\left( s \right)ds$$ $$CU\left( t \right) = \int_{t_{0}}^{t}\nu_{2}\left( s \right)I\left( s \right)ds$$

The daily number of reported cases from the model,$\ DR\left( t \right)$, can be obtained by computing the solution of the following equation:$$\frac{dDR\left( t \right)}{dt} = \nu f\left( t \right)I\left( t \right) - DR\left( t \right)$$ with initial conditions $$DR\left( t_{0} \right) = DR_{0}$$

Both Equation (1a--d) and Equation (6a,b) are here numerically solved through the mixed symbolic-numerical *Mathematica* v.12 platform \[[@B24-biology-09-00220]\], using the built-in function NDSolve, with prescribed relative and absolute errors control to within 10 digits. This routine provides interpolating function objects as output, thus offering a continuous representation of the dependent variables at the completion of the computations. These interpolating functions are then analytically integrated through the Integrate function \[[@B24-biology-09-00220]\] to yield accurate results for the accumulated reported and unreported cases, Equation (5a,b).

3. The Backward SIRU-Type Model {#sec3-biology-09-00220}
===============================

Inverse problem analysis is nowadays a common practice in various science and engineering contexts, in which the groups involved with experiments and numerical simulation collaborate to obtain the maximum information from the available data, towards the best possible use of the modeling for the problem under study. Here, as mentioned in the introduction, we first review an analytical parametric estimation described in more details in References \[[@B4-biology-09-00220],[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220],[@B8-biology-09-00220]\], that from the initial phase of the epidemy evolution allows to explicitly obtain the unknown initial conditions of the model, while offering a reliable estimate for the transmission rate at the onset of the epidemy. Nevertheless, even after these estimates, a few other parameters in the model remain unknown, either due to the specific characteristics of the physical conditions or response to the epidemy in each specific region, or due to lack of epidemiological information on the disease itself. Therefore, an inverse problem analysis was undertaken aimed at estimating the main parameters involved in the model, as summarized in [Table 1](#biology-09-00220-t001){ref-type="table"} below. In case 1, which is associated with the dataset on the accumulated reported cases for China, the focus is on the parametrized time variation of the transmission rate ($\tau_{0}\ {and}\ \mu$), while the fraction of asymptomatic infectious individuals that become reported ($f_{0}$), in this case, it was assumed constant. Then, in case 2, the inverse problem analysis was extended to refine the information on the average times (1/*ν* and 1/*η*) through a simultaneous estimation of the five parameters. Next, in case 3, employing the dataset for Brazil just up to 29 March, the parametrized time variation of the transmission rate ($\tau_{0}\ {and}\ \mu$) and the fraction of asymptomatic infectious individuals that become reported $f\left( t \right)$, assumed time-variable, are estimated by parametrization of an abrupt variation that requires just the estimation of $f_{max}\ {and}\ N_{f}$. Finally, in case 4, the model was redefined for the second stage of the epidemy evolution in Brazil, through estimation of five parameters associated with new time-variable functions for the transmission rate and partition coefficient along this second phase.

The statistical inversion approach here implemented falls within the Bayesian statistical framework \[[@B8-biology-09-00220],[@B9-biology-09-00220],[@B10-biology-09-00220],[@B11-biology-09-00220],[@B12-biology-09-00220]\], in which (probability distribution) models for the measurements and the unknowns are constructed separately and explicitly, as shall be briefly reviewed in what follows.

As explained in previous works employing this model \[[@B4-biology-09-00220],[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220],[@B8-biology-09-00220]\], it is assumed that in the early phase of the epidemy, the cumulative number of reported cases grows approximately exponentially, according to the following functional form:$$CR\left( t \right) = \chi_{1\ }\exp\left( {\chi_{2\ }t} \right) - \chi_{3\ },\ t \geq t_{0}$$

After fitting this function to the early stage of the epidemy evolution, one may extract the information on the unknown initial conditions, in the form \[[@B4-biology-09-00220],[@B5-biology-09-00220],[@B6-biology-09-00220],[@B7-biology-09-00220]\]:$$t_{0} = \frac{1}{\chi_{2}}\lbrack\ln(\chi_{3\ }) - \ln\left( \chi_{1} \right)\rbrack$$ $$I_{0} = \frac{\chi_{3}\chi_{2}}{f_{0}\nu}$$ $$U_{0} = \frac{\left( {1 - f_{0}} \right)\nu}{\eta + \chi_{2}}I_{0}$$

In addition, an excellent estimate for the initial transmission rate can be obtained from the same fitted function, in the form:$$\tau_{0} = \frac{\chi_{2} + \nu}{S_{0}}\frac{\eta + \chi_{2}}{\left( {1 - f_{0}} \right)\nu + \eta + \chi_{2}}$$

Moreover, the basic reproductive number for this initial phase model is estimated as:$$\mathcal{R}_{0} = \frac{\tau_{0}S_{0}}{\nu}{\lbrack{1 + \frac{\left( {1 - f_{0}} \right)\nu}{\eta}}\rbrack}$$

The statistical approach for the solution of inverse problems here adopted employs the Metropolis-Hastings algorithm for the implementation of the Markov chain Monte Carlo (MCMC) method \[[@B8-biology-09-00220],[@B9-biology-09-00220]\]. The MCMC method is used in conjunction with the numerical solution of the ordinary differential system, Equations (1)--(3), for estimating the remaining model parameters. Consider the vector of parameters appearing in the physical model formulation as: is available (**Y**) containing the measurements *Y~m~* at time *t~m~*, *m* = 1, ..., *M.*

Bayes' theorem can then be stated as \[[@B8-biology-09-00220],[@B9-biology-09-00220]\]:$$\pi_{posterior}\left( \mathbf{P} \right) = \pi\left( \mathbf{P} \middle| \mathbf{Y} \right) = \frac{\pi_{prior}\left( \mathbf{P} \right)\pi\left( \mathbf{Y} \middle| \mathbf{P} \right)}{\pi\left( \mathbf{Y} \right)}$$ where $\pi_{posterior}\left( \mathbf{P} \right)$ is the posterior probability density, that is, the conditional probability of the parameters **P** given the measurements **Y**,$\ \pi_{prior}\left( \mathbf{P} \right)$ is the prior density, that is, the coded information about the parameters prior to the measurements, $\pi\left( {\left. \mathbf{Y} \right|\mathbf{P}} \right)$ is the likelihood function, which expresses the likelihood of different measurement outcomes **Y** with **P** given, and $\pi\left( \mathbf{Y} \right)$ is the marginal probability density of the measurements, which plays the role of a normalizing constant. If different *prior* probability densities are assumed for the parameters, the posterior probability distribution may not allow an analytical treatment. In this case, Markov chain Monte Carlo (MCMC) methods are used to draw samples of all possible parameters, and thus inference on the posterior probability becomes inference on the samples \[[@B8-biology-09-00220],[@B9-biology-09-00220]\]. Throughout this work, the mathematical formulation is supposed to perfectly represent the physical problem, and the measurement errors are assumed to be Gaussian random variables, with zero means, known covariance matrix $\mathbf{W}$ and independent of the parameters $\mathbf{P}$. The measurement errors, $\mathbf{\varepsilon}$**,** are assumed to be additive, that is:$$\mathbf{Y} = \mathbf{CR} + \mathbf{\mathbf{\varepsilon}}$$ where, $\mathbf{CR}$ is the vector of solutions of the mathematical formulation (calculated through Equation (5a)), obtained with the vector of parameters $\mathbf{P}$. Due to the additive model for the measurement errors the likelihood function, that gives the relative probability density of different measurement outcomes $\mathbf{Y}$ with a fixed $\mathbf{P}$ can be written as proportional to:$$\pi\left( {\left. \mathbf{Y} \right|\mathbf{P}} \right) \propto e^{- \frac{1}{2}{({\mathbf{Y} - \mathbf{CR}})}^{T}\mathbf{W}^{- 1}{({\mathbf{Y} - \mathbf{CR}})}}.$$

A posterior probability, in Bayesian statistics, can be understood as the "revised" probability of the prior information, after taking into consideration the measurements. However, in this work, it is unfeasible to obtain an analytical posterior distribution through the Bayes theorem, due to the non-linearity of the model and the large space of parameters involved. Thus, the MCMC method is able to provide a picture of the posterior distribution, without solving the mathematical integrals in Bayes' rule. The idea is to approximate the posterior distribution by a large collection of samples of values.

The idea behind the Metropolis-Hasting sampling algorithm is illustrated below, and these steps should be repeated until it is judged that a sufficiently representative sample has been generated:(1)Start the chain with an initial value, that usually comes from any prior information that one may have;(2)Randomly generate a proposed jump aiming that the chain will move around and efficiently explores the region of the parameter space. The proposal distribution can take on many different forms, in this work a Gaussian random walk was employed, implying that the proposed jumps will usually be near the current one;(3)Compute the probability of moving from the current value to the proposed one. Candidates moving to regions of higher probability will be definitely accepted. Candidates in regions of lower probability can be accepted only probabilistically. If the proposed jump is rejected, the current value is tally again. For more details on theoretical aspects of the Metropolis-Hastings algorithm and MCMC methods and its application, the reader should refer to References \[[@B8-biology-09-00220],[@B9-biology-09-00220],[@B10-biology-09-00220],[@B11-biology-09-00220],[@B12-biology-09-00220]\].

4. Results {#sec4-biology-09-00220}
==========

4.1. Model Validation: China {#sec4dot1-biology-09-00220}
----------------------------

Before proceeding to the analysis of the COVID-19 epidemy evolution within Brazil, the proposed direct-inverse problem analysis approach is validated. In this sense, due to the availability of the earliest dataset on this pandemic, we have chosen to use the information from China in terms of the accumulated reported infectious cases. The data for China was extracted from Reference \[[@B6-biology-09-00220]\], complemented by the more recent data from Reference \[[@B25-biology-09-00220]\] from 1 January up to 17 April 2020. The exponential fit for the early phase of the China CR(t) dataset provided the estimates of the three parameters, $\chi_{1} = 0.14936,\ \chi_{2} = 0.37680,\ \chi_{3} = 1.0,$ from which we have estimated $t_{0} = 5.046$. The remaining data for the initial conditions, $I_{0}\ {and}\ U_{0}$, and the early stage transmission rate, $\tau_{0}$, are in fact recalculated from within the MCMC algorithm, since the changing values of *f* will affect them, according to Equation (7c--e). The average times in the model were first taken as 1/*ν* = 7 and 1/*η* = 7 days and the isolation measures were taken at *n* = 25 days \[[@B6-biology-09-00220]\]. First, experimental data from China from the period of 19 January up to 17 February was employed in demonstrating the estimation of three parameters, $f_{0},\ \mu,\ {and}\ \tau_{0},$ assuming there is no significant time variation in the function *f*(*t*) ($\mu_{f} = 0$). In the absence of more informative priors, uniform distributions were employed for all three parameters under estimation. [Table 2](#biology-09-00220-t002){ref-type="table"} presents the prior information and the initial guesses for the parameters. If the initial guesses were used to predict the CR(t) behavior, a marked over-estimation of the accumulated reported infected individuals would occur, especially in the long term, as can be noticed in [Figure 2](#biology-09-00220-f002){ref-type="fig"}, confirming the need for a proper parameter estimation, as will be shown.

The central tendency (mean value) of the posteriors here sampled, after neglecting the first 20,000 burning in states of the chain, are called the estimated values. Both the estimated values and their 99% confidence intervals are presented in [Table 3](#biology-09-00220-t003){ref-type="table"}. It should be mentioned that these values are fairly close to those employed in Reference \[[@B6-biology-09-00220]\], where τ~0~ was estimated as 4.51 × 10^−8^. Once a value of *f~0~* = 0.8 was assumed, which means that 20% of symptomatic infectious cases go unreported, it led to a good agreement with the data by taking *μ* = 0.139 in Reference \[[@B6-biology-09-00220]\].

[Figure 2](#biology-09-00220-f002){ref-type="fig"} also demonstrates the adherence of the model with the data within this portion of the dataset, once the estimated values in [Table 3](#biology-09-00220-t003){ref-type="table"} are employed in the forward problem solution, as can be seen from the excellent agreement between the estimated CR(t) (solid line) and the experimental data from China (blue stars). The desired model validation is illustrated in [Figure 3](#biology-09-00220-f003){ref-type="fig"}, confirming the excellent agreement of China's full dataset (period from 19 January until 16 April) with the mathematical model predictions, after adopting the estimated values for the parameters in [Table 3](#biology-09-00220-t003){ref-type="table"}. It should be recalled that non-informative priors were adopted for the three parameters, as presented in [Table 2](#biology-09-00220-t002){ref-type="table"}, and except for the transmission rate, when Equation (7e) provides an excellent initial guess, the remaining guesses were completely arbitrary. A uniform prior means that all possible values, in the specified limits, are equally likely to be sampled, i.e., no prior information can be distinguished among possible values.

Although the presently estimated parameters have led to a good prediction of the second phase of the China epidemy evolution data, there are still uncertainties associated with the average times here assumed both equal to seven days, according to Reference \[[@B6-biology-09-00220]\]. This choice was based on early observations of the infected asymptomatic and symptomatic patients in Wuhan, but more recent studies have been refining the information on the epidemy evolution and the disease itself, such as in References \[[@B26-biology-09-00220],[@B27-biology-09-00220],[@B28-biology-09-00220]\]. For this reason, we have also implemented a statistical inverse analysis with the full dataset of China, but now seeking the estimation of five parameters, to simultaneously estimate the average times (1/*ν* and 1/*η*). Both uniform and Gaussian distributions were adopted for the two new parameters, with initial guesses of 1/*ν* = 7 days and 1/*η* = 7 days, and *n* = 25 days, as employed in Reference \[[@B6-biology-09-00220]\]. [Table 4](#biology-09-00220-t004){ref-type="table"} presents the prior information and the initial guesses for the parameters.

[Table 5](#biology-09-00220-t005){ref-type="table"} provides the estimated values and 99% confidence intervals for all five parameters, with Gaussian priors for the two average times with data obtained from References \[[@B26-biology-09-00220],[@B27-biology-09-00220],[@B28-biology-09-00220]\], after neglecting the first 15,000 burning in states of the chain. The most affected parameter in comparison with the previous estimates is the average time 1/η, which is also the one with the widest confidence interval. This behavior is also evident from the Markov chains for this parameter, now simultaneously estimated. [Figure 4](#biology-09-00220-f004){ref-type="fig"} compares the theoretical predictions with the model incorporating the five estimated parameters as in [Table 5](#biology-09-00220-t005){ref-type="table"}, against the full CR(t) dataset for China, confirming the improved agreement. The 99% confidence interval bounds for this predicted behavior is also shown in [Figure 4](#biology-09-00220-f004){ref-type="fig"}, bounded by the grey lines.

4.2. Model Application: Brazil {#sec4dot2-biology-09-00220}
------------------------------

The CR(t) data for the accumulated reported infectious in Brazil, from 25 February (day 1), when the first infected individual was reported, up to 29 June (day 127), is presented in [Appendix A](#app1-biology-09-00220){ref-type="app"}. Similarly to the previous example with the data from China, a portion of the available data on accumulated reported infectious was employed in the estimation of model parameters, up to 29 March (day 35), when the present study was initiated. Then, a second portion of the data, from 30 March (day 36) up to 23 April (day 60), was utilized in verifying this first constructed model.

Following the hybrid procedure described above, the exponential phase of the evolution was first fitted, taking the data from day 10 to 25, yielding the estimates of the three parameters, $\chi_{1} = 0.42552,\ \chi_{2} = 0.293696,\ \chi_{3} = 3.2335,$ from which we have estimated $t_{0} = 6.9051$. The remaining data for the initial conditions, $I_{0}\ {and}\ U_{0}$, and the early stage transmission rate, $\tau_{0}$, are in fact recalculated from within the MCMC algorithm, since the changing values of $f_{0}$ will affect them, according to Equation (7c--e). The average times in the model were taken as 1/*ν* = 6.20798 days and 1/*η* = 11.2784 days, which were obtained from the MCMC simulation on the full dataset for China ([Table 5](#biology-09-00220-t005){ref-type="table"}), as discussed in the previous section.

The Brazilian states governments took isolation measures starting on *n* = 21 days, which was enforced by most states and municipalities throughout the country within a few days. Moreover, there were initially only 30,000 exam kits available, and an additional 30,000 were later acquired. However, until mid-April at least, the resulting rather small ration of testing per million inhabitants in Brazil and the retardation in the exam results confirmation, due to a centralized operation, has caused a perceptible change in the data structure for the reported infectious cases, which can only be represented by a time-varying function *f*(*t*). The progressive reduction on the number of executed exams of the symptomatic individuals and the delay of the results availability, has certainly affected the partition of reported to unreported cases by the end of this period covered by the dataset for this first stage. Therefore, the more general model, including the time variation of the partition *f*(*t*), and Equation (4c,d), was here implemented for a more refined inverse problem analysis. It is then expected that a reduction on the f value can be identified ($f_{max} < f_{0}$), with an abrupt variation on the exponential behavior, here assumed as a sharp, functional time dependence (large $\mu_{f}$). Therefore, a statistical inverse problem analysis is undertaken, this time for estimating five parameters, namely, $f_{0},\ \mu,\ \tau_{0},\ f_{max},{\ {and}}\ N_{f}\ $(Case 3---BR5p) aimed at enhancing the overall agreement with the CR(t) data behavior, with a likely reduction on the partition of the reported and unreported infectious cases.

With uniform distributions for all five parameters, guided by the previous estimates for the first three parameters, and arbitrary guesses for $f_{max},{\ {and}}\ N_{f}$, the prior distributions and initial guesses for the five parameters are presented in [Table 6](#biology-09-00220-t006){ref-type="table"} and the five estimated quantities, after neglecting the first 80,000 burning in states of the chain are shown in [Table 7](#biology-09-00220-t007){ref-type="table"}, together with the 99% confidence interval for each parameter.

[Figure 5](#biology-09-00220-f005){ref-type="fig"} presents the predicted evolution of the accumulated reported infectious cases in Brazil, CR(t), from 25 February up to day 150, plotted as the solid black line. Also shown in this figure are the blue crosses in the first portion of the available data, up to 29 March, which were employed in the estimation of the parameters in [Table 7](#biology-09-00220-t007){ref-type="table"}, that compose this initial model. In addition, the red dots represent the second portion of the available data from 30 March until 23 April (day 60), that were not employed in the parametric estimation, but were saved for model validation. It is clear that the built model has an excellent predictive feature, reproducing the epidemy evolution up to the end of the reserved data for validation (up to day 60), with a relative error below 5.8% during this first phase of the epidemy evolution.

One can see the marked reduction on the *f*(*t*) parameter from the estimates in [Table 7](#biology-09-00220-t007){ref-type="table"}, which results in the increase of the unreported to reported infectious cases, as is shown in [Figure 6](#biology-09-00220-f006){ref-type="fig"} for CR(t) and CU(t) predictions up to 150 days. Clearly, the reduction on the testing, and thus, on the isolation of reported infectious individuals, leads to an increase on the total number of infected symptomatic individuals after 150 days (752,888 cases), including unreported (633,698) and reported cases (119,190). Both the reported and unreported infectious individual curves, R(t) and U(t), show a peak at around the 70th day (3 May). Naturally, these projections are inherently assuming that no new interventions or changes in public health would occur from day 35 on, including circulation alterations and more intensive testing, or otherwise, the estimated parameters would not represent such a new phenomenological situation.

The initial phase estimation was repeated, starting with the first 35 data points, and successively implementing another extra 10 points, up to 55 data points. The final behavior of the reported cases to the graphical scale remains essentially the same, reproducing quite well the remaining available data up to around day 65. Therefore, the essential phenomenological characteristics of this initial phase are captured by the adopted 35 points estimates, and was basically confirmed by increasing the number of considered data points. As will be shown in what follows, though this initially constructed model led to an accurate prediction of the actual epidemy evolution even up to around day 65, the data for accumulated reported cases started detaching from the theoretical curve after this period, yielding much higher values after a few weeks. For this reason, it is crucial to implement a scenarios analysis to anticipate such a behavior, based on likely measures or unplanned changes in public health, as will be discussed in the next section.

4.3. Scenarios Analyses: Brazil {#sec4dot3-biology-09-00220}
-------------------------------

Next, the model constructed with this initial parametric estimation is employed in the prediction of the COVID-19 evolution in Brazil under different hypothesis. By the end of this initial period of 60 days, though the proposed model with parameters estimated from the data up to day 35 gave very good predictions, it was already evident that the circulation in the country, as observed from the COVID-19 mobility reports made available \[[@B29-biology-09-00220],[@B30-biology-09-00220]\], was progressively increasing in comparison to the first few weeks after the isolation measures, with respect to workplaces and groceries/pharmacies, especially associated with private vehicles and pedestrian circulation. This tendency becomes more evident after the Easter holiday, corresponding to day 50 onward, and it could be expected that a reduction on the transmissivity attenuation factor would result. Besides, the first set of 500,000 testing kits from a planned amount of 10 million \[[@B31-biology-09-00220]\], finally arrived in Brazil by day 60, with an expected impact on increasing the partition factor, and thus, on increasing the number of reported cases with respect to unreported ones, in the following days. Thus, the prospective scenarios here proposed are aimed at interpreting the epidemy evolution as a result of these two alterations in public health.

Five scenarios were here explored: (i) This is the base case above proposed, assuming that the initial public health interventions remain effective, with the same transmission rate decay due to isolation and the same low partition parameter identified through the first 35 data points; (ii) due to the progressive reduction on part of the circulation modes, a reduction on the transmission rate decay parameter is implemented after day 50, but maintaining the same testing capability as before; (iii) the same reduction on the transmission rate decay parameter of the previous scenario is kept, but now with an increase in the partition coefficient representing an enhanced testing capability starting at day 64; (iv) the transmission rate decay parameter is further reduced, to explore the influence of further circulation increase, while keeping the same fraction of reported cases of the previous scenario, through a more intensive testing; (v) a combination of interventions leading to further increasing the transmission rate by reducing the decay parameter, but simultaneously further increasing the conversion factor of unreported to reported cases with respect to the initially estimated value, *f*~0~.

[Table 8](#biology-09-00220-t008){ref-type="table"} summarizes both the fixed and variable parameter values adopted for these five scenarios. The additional public health interventions simulated in the above scenarios act on either the time variation of the transmission coefficient or on the reported to unreported partition coefficient. The parametric changes are assumed to start at chosen dates further ahead of the initial set of data (day 35), in the present case t = 50 and 64 days (*N*~2~ = 50; *N*~*f*2~ = 64), respectively, for acting on the coefficients, $\tau\left( t \right)$ and $f\left( t \right),$ according to the following parametrizations:$$\tau\left( t \right) = \tau_{0}\ ,\ 0 \leq t \leq N$$ $$\tau\left( t \right) = \tau_{0}\exp\left( {- \mu\left( {t - N} \right)} \right),\ N < t \leq N_{2}$$ $$\tau\left( t \right) = \tau_{02}\exp\left( {- \mu_{2}\left( {t - N_{2}} \right)} \right),\ t > N_{2}$$ with $$\tau_{02} = \tau_{0}\exp\left( {- \mu\left( {N_{2} - N} \right)} \right)$$ $$f\left( t \right) = f_{0}\ ,\ 0 \leq t \leq N_{f}$$ $$f\left( t \right) = \left( {f_{max -}f_{0}} \right)\left\lbrack {1 - \exp\left( {- \mu_{f}\left( {t - N_{f}} \right)} \right)} \right\rbrack + f_{0},\ N_{f} < t \leq N_{f2}$$ $$f\left( t \right) = \left( {f_{max2 -}f_{02}} \right)\left\lbrack {1 - \exp\left( {- \mu_{f2}\left( {t - N_{f2}} \right)} \right)} \right\rbrack + f_{02},\ t > N_{f2}$$ with $$f_{02} = \left( {f_{max -}f_{0}} \right)\left\lbrack {1 - \exp\left( {- \mu_{f}\left( {N_{f2} - N_{f}} \right)} \right)} \right\rbrack + f_{0}$$

In the first scenario, it is assumed that no additional public health interventions are implemented, other than those already reflected by the data up to 29 March (day 35), which would then be fully maintained throughout the control period, and the epidemy should evolve from that date, under the parameters above identified. [Figure 5](#biology-09-00220-f005){ref-type="fig"} has already shown the evolution of the accumulated and instantaneous reported, CR(t) and R(t), unreported, CU(t) and U(t), infectious individuals, up to 150 days. Due to the fairly low value of *f*(*t*) starting with $f_{0} \approx 0.30$ and dropping to $f_{max} \approx 0.16,$ in light of the fairly low number of PCR kits made available and other implementation difficulties during this initial phase, the accumulated number of reported infectious cases is quite low with respect to the unreported ones, as already discussed. No predictions on casualties are here proposed, since these are highly dependent on age structure, social-economic conditions, and health system response. It should be recalled that this initial period of 35 days reflects the strict initial quarantine that was applied at least at the most affected regions, starting in day 21, which is confirmed through the global mobility reports \[[@B29-biology-09-00220],[@B30-biology-09-00220]\]. However, these are ideal conditions that would be rather unlikely to be enforced for a much longer period, due to the sociological and economic characteristics of the country. As will be discussed more closely in what follows, the available mobility reports later on made available have in fact clearly indicated that especially after the Easter holiday weekend (day 50 and on), the circulation was progressively increased in average terms within the country, despite the quarantine measures retained by most of the federation states.

Therefore, the second scenario explores the implementation of a reduced decay of the transmission rate by assuming, after day *N*~2~ = 50 (Equation (10c)), that the value of $\mu$ here identified could be reduced by a factor of 0.2, thus around $\mu_{2}$ = 0.007793. The time variable transmission rate is then computed from Equation (12c) after t \> *N*~2~. The changes in the accumulated reported and unreported cases, as shown in [Figure 7](#biology-09-00220-f007){ref-type="fig"}, are quite significant. The predicted number of unreported symptomatic infectious cases is now much higher reaching after 240 days around 6.14454 × 10^6^ individuals, while the reported cases would reach 1.1436 × 10^6^ individuals, with a total of 7.28814 × 10^6^ symptomatic infected individuals and an impressive difference between reported and unreported cases, due to the maintained low value of $f_{max}$.

Though the reduced decay of the transmission rate shows a more realistic picture of the epidemy evolution after day 60, it is known from the Brazilian Ministry of Health site \[[@B31-biology-09-00220]\] that the PCR testing was markedly intensified after around day 60, corresponding to a total of about 3,820,000 applied tests by 26 June, and continuously increasing, as opposed to only 60,000 tests applied in the initial phase of the epidemy. Therefore, a more realistic picture of the ratio of reported to unreported cases is achieved by simultaneously increasing the partition factor. Through the third scenario, one can predict the consequences of reducing the exponential parameter that affects transmission rate, as in the previous scenario, and increasing by 25% the partition with respect to the initial factor ($f_{max2} = f_{0} \times 1.25$). This is simulated here by progressively increasing the partition factor, starting after day $N_{f2}$ = 64, taking an exponential parameter of $\mu_{f2}$ = 0.05, as expressed by Equation (12g), to allow for a gradual increase in testing. The changes in the accumulated and instantaneous reported and unreported symptomatic cases, as shown in [Figure 8](#biology-09-00220-f008){ref-type="fig"}, are even more significant than in the second scenario (ii), [Figure 7](#biology-09-00220-f007){ref-type="fig"}. The predicted number of accumulated unreported infectious cases is now reaching after 240 days around 3.2041 × 10^6^ individuals, while the reported cases would reach 1.51472 × 10^6^ individuals, with a marked decrease to a total of around 4.71882 × 10^6^ infectious symptomatic cases with respect to scenario (ii). Besides acting on the transmission rate along time, public health measures may also be effective in reducing the overall epidemic dynamics through the ratio of reported to the unreported infectious case, since the reported cases are, in general, directly isolated, and thus, interrupting the contamination path, as demonstrated in this third scenario, where a marked reduction in the total number of symptomatic infectious individuals from around 7.3 to 4.7 million is observed.

By analyzing the data on the percentual average circulation increase from day 50 to day 120 \[[@B29-biology-09-00220],[@B30-biology-09-00220]\], assuming that the transmission rate can be approximately parametrized with the circulation, a reduction on the exponential factor of 0.177 could be expected, lower than that proposed in scenario (iii). Therefore, the fourth scenario examines the effect of further reducing the transmission factor coefficient, again starting at day N~2~ = 50, by a factor of 0.15, thus around *μ*~2~ = 0.005845. The fraction of reported and unreported infectious cases parameter, again reaches $f_{max2} = f_{0} \times 1.25 = 0.3796$, starting at $N_{f2} = 64\ days\ {{with}\ }\mu_{f2} = 0.05,$ such as in the previous scenario. Therefore, [Figure 9](#biology-09-00220-f009){ref-type="fig"} shows the behavior of CR(t), R(t) and CU(t), U(t). The predicted number of unreported infectious cases would now reach, after 240 days, around 5.06029 × 10^6^ individuals, while the reported cases should reach 2.5922 × 10^6^ individuals, with an also marked reduction to a total of around 7.65249 × 10^6^ infectious cases. The predicted total number of infectious cases becomes even higher than that achieved in scenario (ii), illustrating the importance of an accurate estimation of the parameter that governs the temporal attenuation behavior of the transmission factor.

By the time the final revision of this paper was being prepared, different cities and states throughout Brazil were taking partial isolation relaxation measures, while massive testing was being implemented in various locations. In light of the continental dimensions of the country and the fairly heterogeneous and non-simultaneous public health measures, the average overall response to these measures can be analyzed by simultaneously reducing the transmission exponential factor and increasing the maximum partition factor. Therefore, in the fifth scenario, the combination of public health measures affecting both the transmission rate and the conversion factor of unreported to reported cases is analyzed for Brazil. Let us consider that after day N~2~ = 50, the partial relaxation of social distancing leads to a reduction of 0.1 on $\mu$ value previously identified, thus around, $\mu_{2}$ = 0.0038964, and simultaneously increasing the fraction of reported and unreported infectious cases, to provide $f_{max2} = 0.4555$, also starting after $N_{f2} = 64\ days,$ with $\mu_{f2}$ = 0.05. The changes in the accumulated and instantaneous reported and unreported cases are shown in [Figure 10](#biology-09-00220-f010){ref-type="fig"}. The predicted number of unreported infectious cases is now reaching after 240 days around 6.5372 × 10^6^ individuals, while the reported cases should reach 4.74799 × 10^6^ individuals, with a total of 11.2852 × 10^6^ infectious symptomatic cases, around 47.5% increase with respect to the previous scenario with lower transmission rates. Again, through the increased testing, a number of mild symptomatic cases were moved from the unreported to the reported cases evolution, thus moved to monitored isolation earlier, with some impact on the contagious chain, as can be observed through the final ratio of reported to unreported cases. In overall terms, the results for scenario (v) are markedly different from those for the previous scenario (iv), thus pointing out the importance of careful control of the social distancing relaxation measures, together with more intensive testing, to avoid such a marked change.

[Figure 11](#biology-09-00220-f011){ref-type="fig"}a,b combine the data on accumulated reported and total (reported+unreported) infectious symptomatic individuals, respectively, for the predictions provided through the five scenarios here considered. Clearly, scenario (ii), though involving a more mild reduction in transmission rate attenuation coefficient, leads to significant numbers of total symptomatic infectious individuals, close to the values achieved for scenario (iv), essentially due to the fairly low partition factor that was retained in this case. On the other hand, when examining the fairly different total infectious cases curves for scenarios 4 and 5, it is clear that a proper combination of public health interventions, which would involve a more careful control on the relaxation of social distancing and further intensification of testing, should be implemented to achieve final results for scenario (v) closer to (iv), but with less strict circulation restrictions. The red dots in [Figure 11](#biology-09-00220-f011){ref-type="fig"}a represent the actual accumulated reported cases data available up to 29 June. Clearly, these results are already closely represented by the conditions proposed for scenario (iv), without any previous parametric estimation. Such observation offers possible initial guesses for the model redefinition that shall be undertaken in the next section, based on the full dataset available at the completion of this work.

4.4. Model Redefinition: Brazil {#sec4dot4-biology-09-00220}
-------------------------------

The first model construction for Brazil in [Section 4.2](#sec4dot2-biology-09-00220){ref-type="sec"}, employing only the first 35 days of data (up to 29 March) for the parametric estimation task, provided a fairly accurate prediction up to day 65 roughly to within 5% relative error on the accumulated reported cases evolution at this initial stage, which corresponds to the end of April. However, expected alterations on public health measures and behaviors that were initiated in the second half of April, have markedly modified the phenomenological pattern and the corresponding mathematical representation of the epidemy evolution. The scenarios analyzed in the previous section already anticipate the need for a model redefinition through a complementary inverse problem analysis that accounts for the added information from day 36 up to the last data available up to this work completion (day 127). The new parameters to be estimated correspond to those introduced through Equation (10c,d,f,g), not accounted for in the first model proposition and that were varied in the previous scenarios analysis, namely, $\mu_{2}$, $N_{2}$, $f_{max2}$, $\mu_{f2}$, and $N_{f2}$. As previously discussed, there is some prior information for the two date parameters, $N_{2}$ $and\ N_{f2}$, based on the fixed values adopted in the scenarios analysis (days 50 and 64, respectively), and therefore, an informative normal priori was employed for these two parameters. For the other three parameters, non-informative uniform priors were employed, with initial guesses provided by scenario (iv) previously discussed. [Table 9](#biology-09-00220-t009){ref-type="table"} below summarizes the estimated values for the five parameters, together with the corresponding 99% confidence intervals.

[Figure 12](#biology-09-00220-f012){ref-type="fig"} presents the predicted evolution of the accumulated reported and unreported infectious cases in Brazil, CR(t) and CU(t), from 25 February up to day 240, plotted as black and red dashed lines, respectively. Also shown in this figure are the blue crosses in the first portion of the available data, up to 29 March, which were employed in the estimation of the parameters in [Table 7](#biology-09-00220-t007){ref-type="table"} that compose the initially proposed model. In addition, the red dots represent the second portion of the available data from 30 March until 29 June, that were now employed in the parametric estimation for the additional five parameters in [Table 9](#biology-09-00220-t009){ref-type="table"}. The predicted number of unreported infectious cases is now reaching after 240 days around 8.24397 × 10^6^ individuals, while the reported cases reach 3.78342 × 10^6^ individuals, with a total of 12.0274 × 10^6^ infectious symptomatic cases. From the identified value of the partition factor in [Table 9](#biology-09-00220-t009){ref-type="table"}, which is still well below the value encountered from the China analysis, there is space for further intensification of the testing campaigns throughout Brazil, towards a reduction on the total number of symptomatic infectious individuals in the long term.

The short term predictions from the redefined model have also been compared to a statistical simulation that employs a basic logistic growth model \[[@B32-biology-09-00220]\], essentially based on the data for reported infectious individuals. From the application in Reference \[[@B32-biology-09-00220]\] it has been computed from the data up to 29 June, the values of accumulated reported cases estimated from 30 June (day 128) up to 13 July (day 141), with 95% confidence intervals, as shown in [Figure 13](#biology-09-00220-f013){ref-type="fig"} below, together with the predictions of the present redefined model. As can be seen, the present short-term predictions for the days 128 to 141 mostly fall within the 95% confidence interval estimates of the logistic growth model in Reference \[[@B32-biology-09-00220]\].

Finally, [Table 10](#biology-09-00220-t010){ref-type="table"} summarizes the predicted accumulated reported, unreported, and total symptomatic infectious individuals at day t = 240 for each of the five scenarios previously considered and for the redefined model with the full data set for Brazil ([Appendix A](#app1-biology-09-00220){ref-type="app"}). Also shown is the maximum value of the number of instantaneous reported cases, R~max~, and the time of its occurrence, t~max~. Once more, it is quite evident that the first built model with the initial 35 data points could only capture the phenomenological characteristics of the epidemy up to a certain date (roughly up to day 65, as previously discussed). Then, the combination of circulation augmentation and intensified testing led to a markedly different evolution, later confirmed by the redefined model. The marked differences between these two models are observable through the predicted total number of symptomatic individuals at day 240, varying from around 0.75 million in the first model to 12.03 million in the second one. Moreover, the peaks of the instantaneous reported infectious individuals varied from around day 70 in the first model to about day 147 in the second one. In between these two models, one can observe from [Table 10](#biology-09-00220-t010){ref-type="table"}, the number of accumulated symptomatic individuals at 240 days and the reported infections peaks predictions for the other four scenarios. Again we point out the importance of the intensified testing and the proper isolation of those positively tested in the epidemy evolution control, which is evident in the total number of symptomatic individuals, being much lower for scenario (iii) with respect to (ii), while the peak of reported symptomatic cases is noticeably advanced in time (roughly from day 127 down to day 117).

5. Conclusions {#sec5-biology-09-00220}
==============

The present work implements a mixed analytical-statistical inverse problem analysis in the prediction of epidemy evolution, with a focus on the COVID-19 progression in Brazil. A SIRU-type model is adopted, which inherently accounts for the unreported symptomatic infectious individuals. The following aspects can be highlighted in the present study:Time-variable functional parametrizations are proposed for the transmissivity and for the partition of reported and unreported symptomatic cases, which allow for the consideration of public health measures along the epidemy evolution, such as reducing or increasing circulation and intensifying PCR testing while isolating the positively tested individuals.The inverse problem analysis is based on the combination of an analytical parametric estimation for the early phase epidemic exponential behavior with a Bayesian inference approach for a longer following period that encompasses the initial public health interventions to control the epidemics.The evolution of the COVID-19 epidemy in China is considered for validation purposes, by taking the first part of the dataset of accumulated reported infectious individuals to estimate the related parameters, and retaining the rest of the evolution data for direct comparison with the predicted results, with excellent agreement.The same approach is applied to the Brazilian case, this time employing an initial portion of the available time series for the parametric estimates up to day 35, and then offering a validation of the evolution prediction through the initially available remaining dataset up to day 60 (23 April).This first constructed model provides fairly accurate predictions up to day 65 below 5% relative deviation, when the data starts detaching from the theoretical curve.Afterwards, some public health intervention measures are critically examined through five different scenarios, permitting the inspection of their impact on the overall dynamics of the disease proliferation. It was observed that a combination of careful control of the social distancing relaxation and sanitary habits, together with more intensive testing for isolation of symptomatic cases, would be necessary to achieve the overall control of the disease and avoid a second more strict social distancing intervention.The model is then redefined employing the full data set at the completion of this work (day 36 to 127), and new parameters were identified to describe this second phase of the epidemy. Predictions of the reported and unreported symptomatic cases are then offered with the redefined model and briefly compared with a statistical simulation that employs a basic logistic growth model for the short term epidemy behavior.

Further improvement on the modeling is envisioned by enriching the model with latency effects, age structure discrimination, spatial demographic distribution dependence, and recovery factor differentiation among isolated and non-isolated patients.
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###### 

Data for Brazil---accumulated reported cases, CR(t), and casualties.

  DATE               Day   Deaths   Infected   DATE            Day   Deaths   Infected
  ------------------ ----- -------- ---------- --------------- ----- -------- -----------
  24 February 2020   1     0        0          28 April 2020   65    5050     72,149
  25 February 2020   2     0        1          29 April 2020   66    5484     78,416
  26 February 2020   3     0        1          30 April 2020   67    5912     85,507
  27 February 2020   4     0        1          1 May 2020      68    6354     91,604
  28 February 2020   5     0        1          2 May 2020      69    6750     96,559
  29 February 2020   6     0        2          3 May 2020      70    7044     101,227
  1 March 2020       7     0        2          4 May 2020      71    7321     107,780
  2 March 2020       8     0        2          5 May 2020      72    7921     114,715
  3 March 2020       9     0        2          6 May 2020      73    8536     125,218
  4 March 2020       10    0        3          7 May 2020      74    9146     135,106
  5 March 2020       11    0        8          8 May 2020      75    9897     145,328
  6 March 2020       12    0        13         9 May 2020      76    10,627   155,939
  7 March 2020       13    0        19         10 May 2020     77    11,123   162,699
  8 March 2020       14    0        25         11 May 2020     78    11,519   168,331
  9 March 2020       15    0        25         12 May 2020     79    12,400   177,589
  10 March 2020      16    0        34         13 May 2020     80    13,149   188,974
  11 March 2020      17    0        52         14 May 2020     81    13,993   202,918
  12 March 2020      18    0        77         15 May 2020     82    14,817   218,223
  13 March 2020      19    0        151        16 May 2020     83    15,633   233,142
  14 March 2020      20    0        151        17 May 2020     84    16,118   241,080
  15 March 2020      21    0        200        18 May 2020     85    16,792   254,220
  16 March 2020      22    0        234        19 May 2020     86    17,971   271,628
  17 March 2020      23    1        346        20 May 2020     87    18,859   291,579
  18 March 2020      24    4        529        21 May 2020     88    20,047   310,087
  19 March 2020      25    7        640        22 May 2020     89    21,048   330,890
  20 March 2020      26    11       970        23 May 2020     90    22,013   347,398
  21 March 2020      27    18       1178       24 May 2020     91    22,666   363,211
  22 March 2020      28    25       1546       25 May 2020     92    23,473   374,898
  23 March 2020      29    34       1924       26 May 2020     93    24,512   391,222
  24 March 2020      30    46       2247       27 May 2020     94    25,598   411,821
  25 March 2020      31    57       2433       28 May 2020     95    26,754   438,238
  26 March 2020      32    77       2985       29 May 2020     96    27,878   465,166
  27 March 2020      33    92       3417       30 May 2020     97    28,834   498,440
  28 March 2020      34    111      3904       31 May 2020     98    29,314   514,200
  29 March 2020      35    136      4256       1 June 2020     99    29,937   526,447
  30 March 2020      36    159      4589       2 June 2020     100   31,199   555,383
  31 March 2020      37    201      5744       3 June 2020     101   32,548   584,016
  1 April 2020       38    242      6840       4 June 2020     102   34,021   614,941
  2 April 2020       39    299      7911       5 June 2020     103   35,026   645,771
  3 April 2020       40    359      9095       6 June 2020     104   35,930   672,846
  4 April 2020       41    432      10,298     7 June 2020     105   36,455   691,758
  5 April 2020       42    486      11,132     8 June 2020     106   37,134   707,412
  6 April 2020       43    555      12,066     9 June 2020     107   38,406   739,503
  7 April 2020       44    679      13,862     10 June 2020    108   39,680   772,416
  8 April 2020       45    814      16,037     11 June 2020    109   40,919   802,828
  9 April 2020       46    943      17,886     12 June 2020    110   41,828   828,810
  10 April 2020      47    1065     19,730     13 June 2020    111   42,720   850,514
  11 April 2020      48    1131     20,818     14 June 2020    112   43,332   867,624
  12 April 2020      49    1225     22,206     15 June 2020    113   43,959   888,271
  13 April 2020      50    1333     23,604     16 June 2020    114   45,241   923,189
  14 April 2020      51    1541     25,371     17 June 2020    115   46,510   955,377
  15 April 2020      52    1745     28,532     18 June 2020    116   47,748   978,142
  16 April 2020      53    1933     30,449     19 June 2020    117   48,954   1032,913
  17 April 2020      54    2143     33,759     20 June 2020    118   49,976   1067,579
  18 April 2020      55    2359     36,739     21 June 2020    119   50,617   1085,038
  19 April 2020      56    2468     38,688     22 June 2020    120   51,271   1,106,470
  20 April 2020      57    2584     40,616     23 June 2020    121   52,645   1,145,906
  21 April 2020      58    2751     43,131     24 June 2020    122   53,830   1,188,631
  22 April 2020      59    2917     45,976     25 June 2020    123   54,971   1,228,114
  23 April 2020      60    3320     49,711     26 June 2020    124   55,961   1,274,974
  24 April 2020      61    3688     53,448     27 June 2020    125   57,070   1,313,667
  25 April 2020      62    4047     58,973     28 June 2020    126   57,622   1,344,143
  26 April 2020      63    4244     62,208     29 June 2020    127   58,314   1,368,195
  27 April 2020      64    4554     66,541                                    

![Flow chart illustrating the infection path process \[[@B3-biology-09-00220]\].](biology-09-00220-g001){#biology-09-00220-f001}

![Comparison of the theoretical model for reported cases, CR(t), with the initial guesses from [Table 2](#biology-09-00220-t002){ref-type="table"} (black dashed line), against the model prediction with the estimated values from [Table 3](#biology-09-00220-t003){ref-type="table"} (solid black line), and actual data from China from 19 January to 17 February (blue cross)---Case 1: CH3p.](biology-09-00220-g002){#biology-09-00220-f002}

![Comparison of the theoretical model for CR(t) with the three estimated parameter values from [Table 3](#biology-09-00220-t003){ref-type="table"} (solid line), against the dataset for China from 19 January to 17 February (blue stars) and from 18 February to 16 April (red dots)---Case 1: CH3p.](biology-09-00220-g003){#biology-09-00220-f003}

![Comparison of the theoretical model for CR(t) with the five estimated parameter values (solid black line) and 99% confidence intervals (gray lines), against the complete dataset for China from 19 January up to 16 April (blue cross)---Case 2: CH5p.](biology-09-00220-g004){#biology-09-00220-f004}

![Prediction of the accumulated reported infectious, CR(t), with the five estimated parameter values from the available dataset for Brazil from 25 February up to 29 March (blue cross) and validated with the data up to 23 April (red dots).](biology-09-00220-g005){#biology-09-00220-f005}

![Comparison of the theoretical model for CR(t) (dashed black curve), CU(t) (dashed red curve), R(t) (solid cyan curve) and U(t) (solid blue curve) with the five estimated parameter values from the available dataset for Brazil from 25 February up to 29 March. (red dots show available data of CR(t) up to 23 April, day 60).](biology-09-00220-g006){#biology-09-00220-f006}

![Scenario (ii) predictions for CR(t) (dashed black curve), CU(t) (dashed red curve), R(t) (solid cyan curve) and U(t) (solid blue curve) with the five estimated parameter values from the available dataset for Brazil from 25 February up to 29 March.](biology-09-00220-g007){#biology-09-00220-f007}

![Scenario (iii) predictions for CR(t) (dashed black curve), CU(t) (dashed red curve), R(t) (solid cyan curve) and U(t) (solid blue curve) with the five estimated parameter values from the available dataset for Brazil from 25 February up to 29 March.](biology-09-00220-g008){#biology-09-00220-f008}

![Scenario (iv) predictions for CR(t) (dashed black curve), CU(t) (dashed red curve), R(t) (solid cyan curve) and U(t) (solid blue curve) with the five estimated parameter values from the available dataset for Brazil from 25 February up to 29 March.](biology-09-00220-g009){#biology-09-00220-f009}

![Scenario (v) predictions for CR(t) (dashed black curve), CU(t) (dashed red curve), R(t) (solid cyan curve) and U(t) (solid blue curve) with the five estimated parameter values from the available dataset for Brazil from 25 February up to 29 March.](biology-09-00220-g010){#biology-09-00220-f010}

![Comparative predictions for (**a**) CR(t), and (**b**) CR(t)+CU(t), for the five scenarios (i) to (v). (red dots in (**a**) show available data of CR(t) up to 29 June).](biology-09-00220-g011){#biology-09-00220-f011}

![Prediction of the accumulated reported and unreported infectious, CR(t) and CU(t), with the five estimated parameter values from the available dataset for Brazil from 25 February up to 29 March (blue cross) together with the five new estimated parameter values from the data from 30 March to 29 June (red dots).](biology-09-00220-g012){#biology-09-00220-f012}

![Short term prediction of the accumulated reported infectious, CR(t), with the redefined model for Brazil (black dots), and the estimated 95% confidence intervals for a logistic growth model as computed from Reference \[[@B32-biology-09-00220]\].](biology-09-00220-g013){#biology-09-00220-f013}

biology-09-00220-t001_Table 1

###### 

Summary of the estimated parameters on each inverse problem analysis.

  Case                Parameter under Estimation                                Data Range Used in Inverse Problem
  ------------------- --------------------------------------------------------- ------------------------------------
  China                                                                         
  case 1: CH3p        $f_{0},\ \mu,\tau_{0}$                                    19 January up to 17 February
  case 2: CH5p-full   $f_{0},\ \mu,\tau_{0},1/\mathsf{\nu},\ 1/\mathsf{\eta}$   19 January up to 16 April
  Brazil                                                                        
  case 3: BR5p        $f_{0},\ \mu,\ \tau_{0},\ f_{max},\ N_{f}$                25 February up to 29 March
  case 4: BR5p        $\mu_{2}$, $N_{2}$, $f_{max2}$, $\mu_{f2}$, $N_{f2}$      30 March up to 26 June

biology-09-00220-t002_Table 2

###### 

Prior distributions and initial guesses for the parameters to be estimated $f_{0},\ \mu,\ {and}\ \tau_{0}$ (Wuhan, China).

  Case 1: CH3p                                                                                     
  -------------- ------------------------------------------------------- ------------------------- -----------
  $f_{0}$        $U\left\lbrack {0,1} \right\rbrack$                     $0.5$                     estimated
  $\mu$          $U\left\lbrack {0,5} \right\rbrack$                     $0.1$                     estimated
  $\tau_{0}$     $U\left\lbrack {0,\ 1 \times 10^{- 6}} \right\rbrack$   $4.478 \times 10^{- 8}$   estimated
  *S~0~*         11.0 × 10^6^                                            fixed                     
  $t_{0}$        $5.04617$                                               fixed                     
  1/ν            7 days                                                  fixed                     
  1/η            7 days                                                  fixed                     
  N              25                                                      fixed                     
  $\chi_{1}$     $0.14936$                                               fixed                     
  $\chi_{2}$     $0.37680$                                               fixed                     
  $\chi_{3}$     $1.0$                                                   fixed                     

biology-09-00220-t003_Table 3

###### 

Estimated values and 99% confidence intervals for three parameters,$f_{0},\ \mu,{{and}\ }\tau_{0}$ (Wuhan, China).

  Case 1: CH3p                               
  -------------- --------------------------- ----------------------------------------------------------------------------------
  $f_{0}$        $0.780719$                  $\left\lbrack {0.77956,\ 0.7818} \right\rbrack$
  $\mu$          $0.135635$                  $\left\lbrack {0.135219,\ 1.136153} \right\rbrack$
  $\tau_{0}$     $4.47793 \times 10^{- 8}$   $\left\lbrack {4.47793 \times 10^{- 8},\ 4.47793 \times 10^{- 8}} \right\rbrack$

biology-09-00220-t004_Table 4

###### 

Prior distributions and initial guesses for the five parameters to be estimated, $f_{0},\ \mu,\ \tau_{0},\ 1/{\mathsf{\nu}\ {and}\ }1/\mathsf{\eta}$, (Wuhan, China)

  ------------------------------------------------------------------------------------------------------------------
  Case 2: CH5p                                                                                           
  ------------------- ------------------------------------------------------- -------------------------- -----------
  $f_{0}$             $U\left\lbrack {0,1} \right\rbrack$                     0.8                        estimated

  $\mu$               $U\left\lbrack {0,5} \right\rbrack$                     $0.131$                    estimated

  $\tau_{0},\ $       $U\left\lbrack {0,\ 1 \times 10^{- 6}} \right\rbrack$   $4.4779 \times 10^{- 8}$   estimated

  $1/\mathsf{\nu}$    $N\left\lbrack {5.2,\ \sigma = 2.1} \right\rbrack$\     7                          estimated
                      (Min = 1, Max = 21)                                                                

  $1/\mathsf{\eta}$   $N\left\lbrack {10.4,\sigma = 2.6} \right\rbrack$\      7                          estimated
                      (Min = 1, Max = 21)                                                                

  *S~0~*              11.0 × 10^6^                                            fixed                      

  $t_{0}$             $5.04617$                                               fixed                      

  N                   25                                                      fixed                      

  $\chi_{1}$          $0.14936$                                               fixed                      

  $\ \chi_{2}$        $0.37680$                                               fixed                      

  $\ \chi_{3}$        $1.0$                                                   fixed                      
  ------------------------------------------------------------------------------------------------------------------

biology-09-00220-t005_Table 5

###### 

Estimated values and 99% confidence intervals for five parameters, $f_{0},\ \mu,\ \tau_{0},\ 1/{\mathsf{\nu}\ {and}\ }1/\mathsf{\eta}$ (Wuhan, China).

  Case 2: CH5p                                    
  ------------------- --------------------------- ----------------------------------------------------------------------------------
  $f_{0}$             0.718491                    $\left\lbrack {0.711595,\ 0.723138} \right\rbrack$
  $\mu$               0.132032                    $\left\lbrack {0.131789,\ 0.13227} \right\rbrack$
  $\tau 0$            $4.47793 \times 10^{- 8}$   $\left\lbrack {4.47793 \times 10^{- 8},\ 4.47793 \times 10^{- 8}} \right\rbrack$
  $1/\mathsf{\nu}$    6.20798                     \[6.12574, 6.25764\]
  $1/\mathsf{\eta}$   11.2784                     \[10.4379, 12.3593\]

biology-09-00220-t006_Table 6

###### 

Prior distributions and initial guesses for the five parameters to be estimated, $f_{0},\ \mu,\ \tau_{0},\ f_{max},\ N_{f}\ $ (Brazil).

  Case 3---BR5p                                                                                       
  --------------- ------------------------------------------------------- --------------------------- -----------
  *f* ~0~         $U\left\lbrack {0,1} \right\rbrack$                     0.300                       estimated
  $\mu$           $U\left\lbrack {0,\ 5} \right\rbrack$                   $0.04$                      estimated
  $\tau_{0}$      $U\left\lbrack {0,\ 1 \times 10^{- 6}} \right\rbrack$   $1.66755 \times 10^{- 9}$   estimated
  *f~max~*        *U*\[0, 1\]                                             0.165                       estimated
  *N~f~*          *U*\[10, 35\]                                           30.5                        estimated
  1/ν             6.20798 days                                            fixed                       
  1/η             11.2784 days                                            fixed                       
  S~0~            211.3 × 10^6^                                           fixed                       
  $t_{0}$         6.90514                                                 fixed                       
  N               21                                                      fixed                       
  *μ~f~*          10                                                      fixed                       
  *χ~1~*          0.42552                                                 fixed                       
  $\chi_{2}$      0.293696                                                fixed                       
  *χ~3~*          3.2335                                                  fixed                       

biology-09-00220-t007_Table 7

###### 

Estimated values and 99% confidence intervals for five parameters $f_{0},\ \mu,\ \tau_{0},\ f_{max},{\ {and}}\ N_{f}\ $ (Brazil).

  Case 3---BR5p                               
  --------------- --------------------------- ----------------------------------------------------------------------------------
  $f_{0}$         0.303671                    \[0.302624, 0.304697\]
  $\mu$           0.0389639                   \[0.0388438, 0.0390961\]
  $\tau_{0}$      $1.66755 \times 10^{- 9}$   $\left\lbrack {1.66755 \times 10^{- 9},\ 1.66755 \times 10^{- 9}} \right\rbrack$
  $f_{max}$       0.156734                    \[0.156146, 0.157217\]
  $N_{f}$         30.4197                     \[30.3522, 30.4915\]

biology-09-00220-t008_Table 8

###### 

Input data in each scenario for COVID-19 epidemy evolution in Brazil.

  Fixed Parameters                                                                                                                      
  ------------------------------------------ --------------------------- ------------------ --------------------- --------------------- --------------------
  $f_{0}$                                    $0.303671$                                                                                 
  *μ*                                        $0.0389639$                                                                                
  *N*                                        $21$                                                                                       
  $\tau_{0}$                                 $1.66755 \times 10^{- 9}$                                                                  
  $f_{max}$                                  0.156734                                                                                   
  $\mu_{f}$                                  2                                                                                          
  $N_{f}$                                    30.4197                                                                                    
  1/ν                                        6.20798 days                                                                               
  1/η                                        11.2784 days                                                                               
  *S~0~*                                     $211.3 \times 10^{6}$                                                                      
  *t* ~0~                                    $6.90514$                                                                                  
  $\chi_{1}$                                 $0.42552$                                                                                  
  $\chi_{2}$                                 $0.293696$                                                                                 
  $\chi_{3}$                                 $3.2335$                                                                                   
  **Changing Parameters: (50--240th day)**                                                                                              
  **Scenario**                               **(i)**                     **(ii)**           **(iii)**             **(iv)**              **(v)**
  $\mu_{2}$                                  $0$                         $\mu \times 0.2$   $\mu \times 0.2$      $\mu \times 0.15$     $\mu \times 0.1$
  $N_{2}$                                    \-                          50                 50                    50                    50
  $f_{max2}$                                 \-                          \-                 $f_{0} \times 1.25$   $f_{0} \times 1.25$   $f_{0} \times 1.5$
  $\mu_{f2}$                                 0                           0                  0.05                  0.05                  0.05
  $N_{f2}$                                   \-                          64                 64                    64                    64

biology-09-00220-t009_Table 9

###### 

Estimated values and 99% confidence intervals for five parameters, $\mu_{2}$, $N_{2}$, $f_{max2}$, $\mu_{f2}$, and $N_{f2}$ (Brazil).

  Case 4---BR5p                
  --------------- ------------ ------------------------------------------
  $\mu_{2}$       0.00489914   $\lbrack$0.00489891, 0.00489951$\rbrack$
  $N_{2}$         50.2273      \[50.2132, 50.2378\]
  $f_{max2}$      0.384824     \[0.382447,0.386403\]
  $\mu_{f2}$      0.0200351    \[0.020032, 0.0200378\]
  $N_{f2}$        62.1399      \[61.971, 62.3343\]

biology-09-00220-t010_Table 10

###### 

Summary of predicted accumulated reported and unreported cases at day 240 for the scenarios and maximum value and time of instantaneous reported infectious cases (Brazil).

  Scenario                 CR(240) × 10^6^   CU(240) × 10^6^   \[CR(240)+CU(240)\] × 10^6^   R~max~   t~max~
  ------------------------ ----------------- ----------------- ----------------------------- -------- --------
  ($i$)                    0.11919           0.633698          0.752888                      26755    70.2
  ($ii$)                   1.14360           6.14454           7.28814                       127209   127.4
  $\left( {iii} \right)$   1.51472           3.20410           4.71882                       201318   116.9
  ($iv$)                   2.59220           5.06029           7.65249                       300014   129.5
  $\left( v \right)$       4.74799           6.53720           11.2852                       479487   141.9
  New model                3.78342           8.24397           12.0274                       403964   146.9
